🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiujuan Zhang

Thomas Jefferson University

ORCID: 0000-0002-5312-0909

Also affiliated with Yangtze University, Beijing Chao-Yang Hospital, Capital Medical University

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine”.

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Cellular and Molecular Immunology(2020)10.1038/s41423-020-0400-4

N/A

1.1DataRank · unranked

1809 citations

Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang +3 more

Methods for Analysis of Disease Resistance and the Defense Response in Arabidopsis

Methods in Molecular Biology(2013)10.1007/978-1-62703-532-3_6

N/A

0.246DataRank · unranked

3 citations

Xiujuan Zhang, Dongli Wan, Shuqun Zhang, Yiji Xia, Guojing Li

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein

Research Square(2021)10.21203/rs.3.rs-736159/v2

N/A

0.165DataRank · unranked

2 citations

Linfen Huang, Xiujuan Zhang, Jian Shang, Stanley Perlman, Lanying Du +2 more

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

Antiviral Research(2020)10.1016/j.antiviral.2020.104820

N/A

0DataRank · unranked

128 citations

Xiujuan Zhang, Yuxian He, Shibo Jiang, Lanying Du, Wanbo Tai

Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2

Expert Opinion on Therapeutic Targets(2020)10.1080/14728222.2020.1820482

N/A

0DataRank · unranked

65 citations

Xiujuan Zhang, Lanying Du, Shibo Jiang

Neutralizing antibodies for the prevention and treatment of COVID-19

Cellular and Molecular Immunology(2021)10.1038/s41423-021-00752-2

N/A

0DataRank · unranked

148 citations

Yang Yang, Xiujuan Zhang, Lanying Du

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

PLoS Pathogens(2021)10.1371/journal.ppat.1009897

N/A

0DataRank · unranked

78 citations

Wanbo Tai, Victoria K. Baxter, Juan Shi, Yushun Wan, Xiujuan Zhang +16 more

Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies

Nanoscale(2021)10.1039/d1nr03831a

N/A

0DataRank · unranked

40 citations

Yang Yang, Xiujuan Zhang, Fang Li, Lanying Du

Advances in mRNA and other vaccines against MERS-CoV

Translational research(2021)10.1016/j.trsl.2021.11.007

N/A

0DataRank · unranked

32 citations

Xiujuan Zhang, Yang Yang, Jiang Zhu, Lanying Du, Wanbo Tai

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection

UNC Libraries(2021)10.17615/48dn-p307

N/A

0DataRank · unranked

3 citations

Jian Shang, Sharon Taft-Benz, Qibin Geng, Kenneth H. Dinnon, Victoria K. Baxter +16 more

Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein

Research Square(2021)10.21203/rs.3.rs-736159/v1

N/A

0DataRank · unranked

0 citations

Linfen Huang, Xiujuan Zhang, Jian Shang, Stanley Perlman, Lanying Du +2 more

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection

Journal of Virology(2022)10.1128/jvi.00118-22

N/A

0DataRank · unranked

25 citations

Jian Zheng, Wanbo Tai, Abhishek Kumar Verma, Xiujuan Zhang, Qibin Geng +9 more

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge

Translational research(2022)10.1016/j.trsl.2022.04.007

N/A

0DataRank · unranked

19 citations

Jian Zheng, Xiujuan Zhang, Wanbo Tai, Abby Odle, Stanley Perlman +2 more

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection

Virus Research(2023)10.1016/j.virusres.2023.199156

N/A

0DataRank · unranked

19 citations

Jian Zheng, Xiujuan Zhang, Juan Shi, Gang Wang, Xiao‐Qing Guan +4 more

A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies

JCI Insight(2024)10.1172/jci.insight.155789

N/A

0DataRank · unranked

14 citations

Jian Zheng, Xiujuan Zhang, Wanbo Tai, Ryan Compas, Jack Deno +11 more

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Cell Research(2020)10.1038/s41422-020-0387-5

N/A

0DataRank · unranked

161 citations

Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason Hsu, Larry L. Luchsinger +5 more

Neutralizing antibodies for the treatment of COVID-19

Nature Biomedical Engineering(2020)10.1038/s41551-020-00660-2

N/A

0DataRank · unranked

134 citations

Xiujuan Zhang, Yang Yang, Peter J. Hotez, Lanying Du, Shibo Jiang